Article

What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?

Conference|Gastrointestinal Cancers Symposium

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.

Related Videos
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
April 9th 2025

AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
HOPA 2025: Matthew Lei, PharmD, BCOP, Shares Critical Themes and Hot Topic Sessions
April 9th 2025

HOPA 2025: Matthew Lei, PharmD, BCOP, Shares Critical Themes and Hot Topic Sessions

Matthew M. Lei, PharmD, BCOP Alana Hippensteele, Lead Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment Timelines
April 8th 2025

SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment Timelines

Sophie Jabban Alana Hippensteele, Lead Editor
Expert Insights: At APhA 2025, Pharmacists Reaffirmed Their Essential Role in Patient Care
April 8th 2025

Expert Insights: At APhA 2025, Pharmacists Reaffirmed Their Essential Role in Patient Care

Kennedy Ferruggia, Assistant Editor Luke Halpern, Assistant Editor